Literature DB >> 24652550

Predictive impact of the decreasing rate of intrathoracic impedance in worsening chronic heart failure.

Shinya Yamada1, Hitoshi Suzuki, Yoshiyuki Kamiyama, Shu-ichi Saitoh, Yasuchika Takeishi.   

Abstract

PURPOSE: Intrathoracic impedance monitoring is useful for heart failure (HF) management in patients with cardiac resynchronization therapy (CRT). However, more accurate identification of worsening chronic HF (CHF) is required in the clinical setting. We investigated this issue by estimating changes in impedance.
METHODS: We studied 38 CHF patients (29 males, mean age 67 years) with CRT-defibrillator capable of impedance monitoring. During the follow-up period (20.7 ± 7.8 months), the subjects experienced a total of 129 fluid index threshold (60 ohm·days) crossing events. These events were divided into two groups: HF events (n = 70) and no HF events (n = 59). Based on the impedance at the beginning of increasing fluid index (S) and at the crossing of 60 ohm·days (E), the rate of impedance change (S - E / S) was estimated. In addition, the elapsed time from S to E (T) was evaluated. Then, we calculated the rate of impedance change per day (S - E / S × T) in each group.
RESULTS: The rate of impedance change per day was significantly higher in HF events than in no HF events (0.86 ± 0.48 vs. 0.37 ± 0.22%/day, P < 0.01). By receiver operating characteristic curve for identification of HF events, the best cutoff value of the rate of impedance change was 0.48%/day (sensitivity 80%, specificity 81%, and area under the curve 0.85).
CONCLUSIONS: These results suggest that a faster drop in intrathoracic impedance reflected worsening CHF in patients with CRT-defibrillator. Thus, intrathoracic impedance monitoring based on the rate of impedance change may provide a more accurate identification of worsening CHF.

Entities:  

Mesh:

Year:  2014        PMID: 24652550     DOI: 10.1007/s10840-014-9881-3

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  11 in total

1.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

2.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Authors:  Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

3.  Intrathoracic impedance monitoring to predict decompensated heart failure.

Authors:  Claudia Ypenburg; Jeroen J Bax; Ernst E van der Wall; Martin J Schalij; Lieselot van Erven
Journal:  Am J Cardiol       Date:  2007-01-02       Impact factor: 2.778

4.  Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST).

Authors:  William T Abraham; Steven Compton; Garrie Haas; Blair Foreman; Robert C Canby; Robert Fishel; Scott McRae; Gloria B Toledo; Shantanu Sarkar; Douglas A Hettrick
Journal:  Congest Heart Fail       Date:  2011-03-21

5.  The natural history of congestive heart failure: the Framingham study.

Authors:  P A McKee; W P Castelli; P M McNamara; W B Kannel
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

6.  Efficacy of fluid assessment based on intrathoracic impedance monitoring in patients with systolic heart failure.

Authors:  Yoshimitsu Soga; Kenji Ando; Takeshi Arita; Makoto Hyodo; Masahiko Goya; Masashi Iwabuchi; Masakiyo Nobuyoshi
Journal:  Circ J       Date:  2010-11-28       Impact factor: 2.993

7.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

8.  Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.

Authors:  Cheuk-Man Yu; Li Wang; Elaine Chau; Raymond Hon-Wah Chan; Shun-Ling Kong; Man-Oi Tang; Jill Christensen; Robert W Stadler; Chu-Pak Lau
Journal:  Circulation       Date:  2005-08-01       Impact factor: 29.690

9.  Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.

Authors:  Roy S Small; William Wickemeyer; Robin Germany; Bobbi Hoppe; John Andrulli; Peter A Brady; Melody Labeau; Jodi Koehler; Shantanu Sarkar; Douglas A Hettrick; W H Wilson Tang
Journal:  J Card Fail       Date:  2009-03-17       Impact factor: 5.712

10.  Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.

Authors:  Cheuk-Man Yu; Wing-Hong Fung; Hong Lin; Qing Zhang; John E Sanderson; Chu-Pak Lau
Journal:  Am J Cardiol       Date:  2003-03-15       Impact factor: 2.778

View more
  1 in total

1.  Intracardiac impedance after cardiac resynchronization therapy is a novel predictor for worsening of heart failure.

Authors:  Hitoshi Suzuki; Minoru Nodera; Masashi Kamioka; Takashi Kaneshiro; Yoshiyuki Kamiyama; Yasuchika Takeishi
Journal:  Heart Vessels       Date:  2017-02-08       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.